Project LOLA (Liquid Biopsy, Lung and Colon Cancer in Andalusia), which is coordinated by Dr. María José Serrano, principal investigator of the ‘Liquid Biopsy and Cancer Interception’ group of the Pfizer-University of Granada-Andalusia Centre for Genomics and Oncology Research (GENYO) and the Institute for Biosanitary Research of Granada (ibs. GRANADA), starts with the aim of revolutionising the diagnosis and treatment of lung and colon cancer in the Andalusian Public Health System. This will be possible thanks to the incorporation of liquid biopsies and the use of advanced next-generation sequencing technologies.

Read the full article: https://www.elindependientedegranada.es/economia/ibsgranada-lidera-proyecto-lola-deteccion-no-invasiva-cancer-pulmon-colon

See more news